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INTRODUCTION
Over the last few decades, much effort has been
expended to improve the accuracy of plasma creatinine
(Pcr) based glomerular filtration rate (GFR) estimating
equations, and many equations had been published
(Table) [1–9]. Before the publication of the
Modification of Diet in Renal Disease (MDRD) study
equation, the main GFR estimating equation that
was used in Mainland China was the Cockcroft-Gault
(C-G) equation [4]. In 1999, Levey et al published
the MDRD equations [8]. In 2000, the authors
simplified the MDRD equation [9]. In 2006, the
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MDRD equations were re-expressed [10], and in that
same year, Ma et al modified the MDRD equation for
Chinese patients with chronic kidney disease (CKD)
[11].
With the numerous GFR estimating equations
available, which is the most appropriate, especially in
Chinese patients with CKD? In this review, methods
on how different equations can be compared will be
discussed, the importance of calibration of Pcr will be
emphasized, and some tricky issues on the development
of these equations will be presented, which should be
helpful in aiding our selection of the most appropriate
equation to use.
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C-G EQUATION AND ABBREVIATED MDRD
EQUATION
These equations are the two that are most used in
Mainland China. However, there are several limitations
to the C-G equation. (1) The reference GFR was 24-
hour urinary creatinine clearance (Ccr), so the predicted
value of the C-G equation is actually Ccr in the unit of
mL/min; (2) the sample size was 236, and all of them
were male. In the discussion section, the authors
suggested that “Various authors have recommended
reducing the predicted Ccr by 10–20% (for females).
A 15% reduction appears appropriate.” [4].
On the other hand, the MDRD equations seem to
be perfect. The renal clearance of 125I-iothalamate was
used as reference GFR in the development of the
equations, and the sample size was relatively large. It
was expected that the MDRD equations would output
a more accurate estimate of GFR (eGFR), but it seems
that these equations significantly underestimate GFR
when the real value is in the near-normal range [12–
17], and overestimate GFR in advanced kidney failure
[16,17]. This phenomenon exists not only in Whites
and African-Americans, but also in other racial groups.
We also found this trend in Chinese patients with CKD.
By including a racial factor for Chinese into the MDRD
equation, this trend was significantly reduced [11] but
still existed. This is partly due to the problem of
regression, and partly due to the racial differences
among Whites, African-Americans and Chinese. The
exact rationale behind this is not clear, and more work
needs to be done. But we postulated that the following
factors might be involved: (1) the body composition of
Chinese is different from that of Whites or African-
Americans; (2) the amount of protein intake and
preference for the types of protein are different between
Chinese and Whites.
PROBLEM OF REGRESSION IN GFR EQUATION
DEVELOPMENT
There is no physiologic basis for GFR equations; they
are just empirical statistical regression equations. When
we fit a regression model, it means that you are telling
the model, “I think these variables can predict GFR,
Table. Plasma creatinine based equations
Authors (year) [reference]
Ccr (mL/min) = 100 – 12 for male
 Pcr
Ccr (mL/min) =  80  – 7 for female
 Pcr
Jelliffe & Jelliffe (1971) [1]
Ccr (mL/min) = Weight
2
  [29.3 – 0.203  Age]  [1 – 0.03  Pcr]
  for male
 14.4  70  Pcr
Ccr (mL/min) = Weight
2
  [25.3 – 0.175  Age]  [1 – 0.03  Pcr]
  for female
 14.4  70  Pcr
Mawer et al (1972) [2]
Ccr (mL/min) = 27 – 0.173  Age  Weight  0.07  for male
 Pcr
Ccr (mL/min) =  25 – 0.175  Age  Weight  0.07  for female
 Pcr
Bjornsson et al (1983) [6]
Ccr (mL/min) =  98 – 0.8  (Age – 20)   (0.9 if female)
 PcrJelliffe (1973) [3]
Ccr (mL/min) =  (140 – Age)  Weight   (0.85 if female)
 72  PcrCockcroft & Gault (1976) [4]
Ccr (mL/min) =  [(145 – Age) / Pcr – 3] Weight   (0.85 if female)
 70Hull et al (1981) [5]
Ccr (mL/min) =  89.4  Pcr–1.2 + (55 – Age)  0.447  Pcr–1.1 for male
Ccr (mL/min) =  60  Pcr–1.1 + (56 – Age)  0.3  Pcr–1.1 for femaleGates (1985) [7]
GFR (mL/min/1.73 m2) =  170  Pcr–0.999  Age–0.176  SUN–0.170  Alb0.318
                                            (0.762 if female)  (1.18 if Black)Levey et al (1999) [8]
GFR (mL/min/1.73 m2) =  186  Pcr–1.154  Age–0.203  (0.742 if female)Levey et al (2000) [9]
Equation
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GFR estimating equation
do it for me”. The software then does the model fitting
as instructed, and tells you how well the model fits.
Usually, GFR cannot be wholly explained by the
dependent variables. This is partly due to the random
error in measurement of dependent variables and
reference GFR, and partly due to the fact that not all
dependent variables are included in the model. This is
to say that the model cannot perfectly reflect the real
world as it is. There are several factors that may
influence the accuracy of eGFR.
Reference GFR
Until now, the renal clearance or plasma clearance of
inulin has been considered to be the best estimate of
GFR. Other reference GFR methods include clearance
of diethylenetriamine pentaacetic acid (DTPA) and
ethylenediamine tetraacetic acid (EDTA). In any case,
no reference method can give error-free results.
Nevertheless, the diurnal variation in GFR can be as
large as 10–20% [18–20], and Pcr cannot reflect this
acute daily variation. Furthermore, there are systemic
differences between different reference GFR methods.
For example, studies have shown that results of DTPA
plasma clearance by dual plasma sampling method
overestimates GFR by an average of 0.5 mL/min when
GFR = 10 mL/min, and underestimates GFR by an
average of 20 mL/min when GFR = 100 mL/min [21].
Renal clearance of iothalamate, used as the standard
measure of GFR in the MDRD study, overestimated
renal clearance of inulin by 3–5 mL/min at low levels
of GFR and by 15–25 mL/min in healthy subjects [22,
23]. When we fit the models, we are actually requesting
the computer to predict DPTA plasma clearance or
iothalamate renal clearance, not the “real” GFR. The
systemic difference between reference GFR methods
will definitely result in different GFR predicting
equations.
Plasma creatinine
Pcr can be measured using different methods, such as
kinetic Jaffe’s method, enzyme method, etc. And each
method can be performed using different autoanalyzers.
This will induce intralaboratory variation. For example,
for the same plasma samples, the Pcr values reported
by the MDRD study (Beckman Astra CX3 auto-
analyzer; Brea, CA, USA) were 0.23 mg/dL lower
than values reported by the National Health and
Nutrition Examination (NHANES) III (Hitachi 737
analyzer; Boehringer Mannheim Corp, Indianapolis,
IN, USA) [24], although both of them used the modified
kinetic Jaffe reaction method to measure Pcr. If the
MDRD plasma samples were to be measured in a third
laboratory, and the Pcr was 5% systemically higher than
the MDRD value, then the coefficient of 186 in the
abbreviated MDRD equation would change to [186 ×
(–1.154) × ln(1/1.05) =] 196; and if the Pcr was 5%
systemically lower, it would change to [186 × (–1.154)
× ln(1/0.95) =] 175. Very recently, Levey et al calibrated
the Beckman assay used in the MDRD study to the
Roche/Hitachi P module Creatinase Plus enzymatic
assay (Roche Diagnostics, Basel, Switzerland), which
was traceable to an isotope-dilution mass spectrometry
assay at the National Institute of Standards and
Technology [25]. By doing so, the coefficient of
abbreviated MDRD equation was changed from 186 to
175 [10]. Clearly, different Pcr methods will result in
different eGFR estimating equations.
Regression model cannot reflect real world
A big problem in eGFR equation development is that
the regression model cannot reflect the real world. Both
the MDRD study and Ma et al’s study assumed that
log transformed Pcr would be linearly related to real
GFR. Although nowadays, this is the best model to
describe the relationship between Pcr and GFR, it is in
fact not the real world. As we know, because of the
tubular secretion of creatinine, Pcr will not increase in
the early stage of GFR decrease, so the model will relate
an apparently normal Pcr with a decreased GFR, and
fit the data to output an eGFR equation. When this
equation is used in normal individuals who have normal
Pcr values and normal real GFR, the eGFR will
definitely be lower than the real value. In 2004, Rule et
al developed new Pcr-based equations for potential
kidney donors, an apparently normal population [26].
The next year, Froissart et al applied these equations to
another series of potential kidney donors, and found
that the new equations did not perform better than the
original abbreviated MDRD equations [27]. But in a
12-year-survival study performed in an aged population,
Rule et al’s equation was a strong predictor of death,
while the MDRD equation was not [28]. Although Rule
et al’s equation might be a little bit better than the
original MDRD equation when applied to a normal
population, it seems impossible to accurately predict
real GFR in this group of individuals. Recently,
researchers tried to include cystatin C in the GFR
estimating equation [29], which might improve the
accuracy of estimated GFR. At present, there is no
acceptable equation to estimate GFR in the general
Chinese population.
Relationship between log transformed Pcr and
real GFR not always linear
Another problem is that the model will strictly obey
your instruction to keep the linear relationship between
log transformed Pcr and log transformed real GFR,
although sometimes it does not reflect the real situation.
So when GFR is relatively normal, a small change in
Pcr would result in a disproportionately great change
in eGFR. For example, say we have a 40-year-old White
male with CKD; 2 weeks ago, his Pcr was 0.55 mg/dL.
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According to the abbreviated MDRD equation, his
eGFR would be 175 mL/min/1.73 m2. At his doctor
visit today, his Pcr was 0.60 mg/dL, and his eGFR
would therefore be 159 mL/min/1.73 m2. The difference
between the two Pcr values is only 0.05 mg/dL, which
might be due to laboratory variation, but the resulting
difference in the two eGFR values was large, at 16 mL/
min/1.73 m2.
COMPARING DIFFERENT GFR ESTIMATING
METHODS
To decide which method is better, or whether these two
methods are equivalent, we need to make some
comparison. Correlation should not be used to describe
agreement between methods. This is because highly
correlated methods still have the possibility of being
systemically different from each other. This issue has
been fully discussed by Bland and Altman [30].
Regressing one method against another method should
also be avoided. Two equivalent methods may be
erroneously judged to be not equivalent by regression;
this phenomenon is called “regression toward the mean
(RTM)”.
The phenomenon of RTM will be shown here by an
example. Suppose we have 300 subjects, the mean real
GFR is 60 mL/min/1.73 m2, and the standard deviation
is 20 mL/min/1.73 m2. For each subject, eGFR is
estimated using a given method with normal distributed
random error, suppose the standard deviation for each
subject is 15% of the real GFR, we will call this eGFR1.
eGFR is measured again using the same method with
the same standard deviation, we will call this eGFR2.
eGFR1 and eGFR2 are equivalent to each other apart
from the random error. If we regress eGFR2 against
eGFR1 (Figure 1A), the intercept would be 10.68 ±
2.02 (significantly different from 0, p < 0.0001), and
the slope would be 0.83 ± 0.03 (significantly different
from 1, p < 0.0001) in this simulation. This result would
mislead one to conclude that there is a systemic
difference between eGFR2 and eGFR1. This is not a
coincidence, if eGFR1 is regressed against eGFR2, the
intercept is again greater than 0 and the slope is again
less than 1 (Figure 1B). So, when we compare two
methods, we cannot simply regress one against the
Figure 1. Artifact that two methods are not equivalent when they are actually equivalent. (A) Regressing method 2 against method 1.
(B) Regressing method 1 against method 2. The dashed line is the identical line; the solid line is the regression line.
A B
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GFR estimating equation
other. The proper method to compare eGFR1 and
eGFR2 is with the Bland-Altman plot [30]. In the
Bland-Altman plot, the difference between eGFR2 and
eGFR1 is plotted against the average of them, and the
95% confidence interval of difference is also shown
(Figure 2A). It clearly shows that eGFR1 and eGFR2
perfectly agree with each other (the average difference
is 0.04 ± 12.85 mL/min/1.73 m2).
When comparing different methods, many papers
(including our paper [16]) expand the Bland-Altman
plot by regressing difference against average, and claim
that if the slope is not equal to 0, then the difference is
proportional to average. The fact is that the slope can
also be caused by different size of intrasubject variance
between methods. We will use the above 300 subjects
with mean real GFR of 60 mL/min/1.73 m2 and standard
deviation of 20 mL/min/1.73 m2 to illustrate why.
Suppose the above real GFR is estimated by method 1
and method 2 with normal distributed random error,
and the intrasubject standard deviation for these two
methods is 15% and 7% real GFR, respectively. There
is no significant difference between the two methods
using paired t test. The Bland-Altman regression looks
like that shown in Figure 2B. The slope is –0.10 ± 0.03
(significantly different from 0, p < 0.001), and the
intercept is 4.06 ± 1.24 mL/min/1.73 m2 (significantly
different from 0, p = 0.002) in this simulation. The real
world is that there is no systemic difference between
method 1 and method 2, and the slope and intercept
should both be 0.
The slope is useful when two methods are compared
with a certain reference method. By comparing method
1 with the reference and comparing method 2 with the
reference, we get two Bland-Altman regression slopes.
The method with a near 0 slope is expected to be better
than the other one (mean difference and its 95%
confidence interval should also be considered). In our
previous work, performance of the MDRD equation in
Chinese patients with CKD was evaluated, the
difference between MDRD equation estimated GFR
and reference GFR was regressed against their mean,
and the slope was significantly < 0. We concluded that
the MDRD equation underestimates reference GFR
when real GFR is in the near-normal range [16]. In the
discussion section, we should have mentioned the
possibility of different error sizes between the MDRD
equation and the reference GFR method that could
cause the non zero slope. This is a shortcoming.
Figure 2. Bland-Altman plots. (A) Typical Bland-Altman plot: intrasubject variances are equal between two methods. (B) Bland-
Altman plot when the intrasubject variances are unequal between two methods.
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Recently, using the same dataset, we modified the
MDRD equation [11]. In this study, the modified
MDRD equation and original MDRD equation were
compared with reference method. It was shown that
the slopes of Bland-Altman regressions for the modified
equations were much closer to 0 than that of the original
equations, which means that the modified equation
performs better. But the slope was still non zero. We
did not know which condition caused this non-zero
slope: the difference of error size of method, the real
trend of difference along average, or the regression
problem mentioned above.
IMPORTANCE OF CALIBRATION FOR CREATININE
METHOD
Creatinine calibration is a big issue in GFR estimation.
If Pcr is systemically high or low, then eGFR will
dramatically shift away from the real GFR. Many
authors have emphasized the importance of calibration
of creatinine [10,24,31–34]. Suppose we have a group
of 1,000 male subjects, all 40 years old, and their
Pcr values are 0.30, 0.31, 0.32…15.00 mg/dL,
respectively. We calculate eGFR for each of them
using the abbreviated MDRD equation, and plot eGFR
against Pcr (the solid curve in Figure 3). The upper
and lower dashed curves represent deviated eGFR if
Pcr is 5% low or high. It is clear that a small change
in creatinine causes eGFR to significantly deviate from
its real value.
EQUATION SELECTION AND RESULT
EXPLANATIONS
With Pcr in hand, you need to select one of the Pcr-
based equations to estimate eGFR. Several factors will
influence your selection, such as race and method of
creatinine. You are advised to select the equation
specific for a certain racial group, and which uses the
same creatinine method as yours.
We have just finished a survey study, which is aimed
at finding the disease burden of CKD in Beijing. This
was a multistage complex designed survey. Pcr was
measured in the laboratory that measured Pcr when we
developed our equation. The preliminary results
(unpublished data) showed that if the original MDRD
equation is used for eGFR calculation, the prevalence
of eGFR < 60 mL/min/1.73 m2 would be 2.2%, which
represents 298,522 individuals in Beijing. But if the
equation specific for Chinese is used, the prevalence
of decreased eGFR would be 1.7%, which represents
about 230,676 individuals (Beijing residents in the year
2000 were used as the denominator).
It is a good idea to send your plasma specimens to
the laboratory that developed the equations to have the
Pcr measured. But it is cumbersome and also impossible
for all renal centers to do so. The re-expressed MDRD
equations used the standardized creatinine method [10].
Any renal center can have their creatinine value cali-
brated to the standardized creatinine value without
having to send their specimens to the laboratory where
the MDRD study measured their creatinine.
Figure 3. Importance of calibration of creatinine measurement. The solid curve shows the real creatinine values. The curve shifts
upward if creatinine is systemically low and downward if creatinine is systemically high. For a 40-year-old White male, if real creatinine
= 1 mg/dL, his eGFR is 88 mL/min/1.73 m2. If creatinine changes 5% within the real value (0.95–1.05 mg/dL), the corresponding eGFR
will change from 79 to 100 mL/min/1.73 m2. If the real creatinine is 2 mg/dL, ± 5% change in creatinine (1.9–2.1 mg/dL) will cause
eGFR to vary from 35 to 45 mL/min/1.73 m2.
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If the eGFR equation is used for survey study, the
Pcr method should be calibrated, otherwise, the
estimated prevalence or incidence will significantly
deviate from their real value. For outpatient practice,
although systemically biased Pcr will result in
systemically biased eGFR, it is still useful to estimate
the trend in eGFR over time. If the absolute value of
eGFR is not important to you, and your interest is the
overall trend in eGFR, an uncalibrated Pcr would be of
no harm.
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